Rituxan
| Rituxan | |
|---|---|
| Term | Rituxan |
| Short definition | Rituxan - (pronounced) (rih-TUK sun) medicine that contains the active substance rituximab, used alone or with other medicines to treat adults and children 6 months and older with certain types of B-cell non-Hodgkin's lymphoma, adults with chronic lymphocytic leukemia and children 6 months and older elderly with acute B-cell leukemia. It is used in patients whose cancer is CD20 positive. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Rituxan - (pronounced) (rih-TUK sun) medicine that contains the active substance rituximab, used alone or with other medicines to treat adults and children 6 months and older with certain types of B-cell non-Hodgkin's lymphoma, adults with chronic lymphocytic leukemia and children 6 months and older elderly with acute B-cell leukemia. It is used in patients whose cancer is CD20 positive. It is also being studied in the treatment of other diseases and cancers. Rituxan attaches to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This can help the immune system kill cancer cells. Rituxan is a type of monoclonal antibody
External links
- Medical encyclopedia article on Rituxan
- Wikipedia's article - Rituxan
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski